Nanotech Investing Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome , a Rare Pediatric Congenital Heart Defect
Nanotech Investing Longeveron® to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
Nanotech Investing George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors
Nanotech Investing Longeveron® to Attend Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa
Nanotech Investing Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Apex Commences Drilling at Jersey Emerald Property and Announces Amendment to Terms of Lithium Creek Option Agreement
Sranan Gold Announces Participation in Upcoming 121 Mining Investment London and Swiss Mining Institute Conferences